Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | F10 | P00742 | 2/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
| ▸ | LOX | P28300 | 2/20 | 0.34 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.33 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24370727 | 0.92 | SMN1; SMN2 (0.45) | ALDH1A1SMN1; SMN2F10HDAC3SPHK2 | |
| SCHEMBL13634584 | 0.88 | F10 (0.42) | ALDH1A1SMN1; SMN2F10HDAC3SPHK2 | |
| SCHEMBL21546126 | 0.88 | F10 (0.42) | ALDH1A1SMN1; SMN2F10HDAC3SPHK2 | |
| SCHEMBL30587015 | 0.88 | F10 (0.42) | ALDH1A1SMN1; SMN2F10HDAC3SPHK2 | |
| SCHEMBL24370728 | 0.88 | MAOB (0.44) | MAOBALDH1A1SMN1; SMN2F10HDAC3 | |
| SCHEMBL13525981 | 0.86 | F10 (0.38) | ALDH1A1F10HDAC3SPHK2GAA | |
| SCHEMBL26167876 | 0.86 | LOX (0.43) | ALDH1A1SMN1; SMN2F10HDAC3SPHK2 | |
| SCHEMBL23106220 | 0.83 | ALDH1A1 (0.37) | MAOBALDH1A1SMN1; SMN2HDAC3GAA | |
| SCHEMBL26010471 | 0.83 | ALDH1A1 (0.37) | MAOBALDH1A1SMN1; SMN2F10HDAC3 | |
| SCHEMBL24199561 | 0.83 | F10 (0.40) | ALDH1A1F10HDAC3SPHK2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067673-A1 | MODIFIED NUCLEOSIDE OR NUCLEOTIDE | BGI SHENZHEN (CN) | 2024-02-29 | — | — | US | disclosed |
| EP-4234566-A1 | MODIFIED NUCLEOSIDE OR NUCLEOTIDE | BGI Shenzhen (CN) | 2023-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240067673-A1 | MODIFIED NUCLEOSIDE OR NUCLEOTIDE | NT5C3B, NT5E, NT5C2 | MAOB 1512/4885ALDH1A1 1758/4885SMN1; SMN2 2470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.